Rapid and sensitive UHPLC-DAD method for simultaneous determination of sofosbuvir and ledipasvir in human serum.

[1]  Sherin F Hammad,et al.  Earth-friendly spectrophotometric methods for simultaneous determination of ledipasvir and sofosbuvir: Application to average content and uniformity of dosage unit testing. , 2018, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[2]  M. Sohrabi,et al.  Chemometric simultaneous determination of Sofosbuvir and Ledipasvir in pharmaceutical dosage form. , 2018, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[3]  A. El-Olemy,et al.  Spectroflurimetric estimation of the new antiviral agent ledipasvir in presence of sofosbuvir. , 2018, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[4]  L. Abu-Raddad,et al.  The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses , 2018, Scientific Reports.

[5]  Y. Vander Heyden,et al.  Method optimization for drug impurity profiling in supercritical fluid chromatography: Application to a pharmaceutical mixture. , 2017, Journal of chromatography. A.

[6]  Amol A. Kulkarni,et al.  DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF LEDIPASVIR AND SOFOSBUVIR IN BULK AND PHARMACEUTICAL DOSAGE FORM , 2017 .

[7]  Ahmed M Abdel-Megied,et al.  Development a validated highly sensitive LC–MS/MS method for simultaneous quantification of Ledipasvir, sofosbuvir and its major metabolite GS‐331007 in human plasma: Application to a human pharmacokinetic study , 2017, Journal of pharmaceutical and biomedical analysis.

[8]  M. Eissa.  Simultaneous determination of the brand new two-drug combination for the treatment of hepatitis C: Sofosbuvir/ledipasvir using smart spectrophotometric methods manipulating ratio spectra. , 2017, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[9]  C. Stedman,et al.  Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection. , 2017, Gastroenterology.

[10]  A. El-Olemy,et al.  Application of TLC Densitometric Method for Simultaneous Estimation of the Newly Co-formulated Antiviral Agents Ledipasvir and Sofosbuvir in Their Tablet Dosage Form , 2017 .

[11]  M. Hassouna.  Assay and Dissolution Methods Development and Validation for Simultaneous Determination of Sofosbuvir and Ledipasvir by RP-HPLC Method in Tablet Dosage Forms , 2017 .

[12]  Bakht Zaman,et al.  RP-HPLC Method for Simultaneous Determination of Sofosbuvir and Ledipasvir in Tablet Dosage Form and Its Application to In Vitro Dissolution Studies , 2016, Chromatographia.

[13]  Emad B. Basalious,et al.  Quantification of sofosbuvir and ledipasvir in human plasma by UPLC-MS/MS method: Application to fasting and fed bioequivalence studies. , 2016, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[14]  S. Wilhelm,et al.  New direct-acting antivirals in hepatitis C therapy: a review of sofosbuvir, ledipasvir, daclatasvir, simeprevir, paritaprevir, ombitasvir and dasabuvir , 2016, Expert review of clinical pharmacology.

[15]  Yongping Chen,et al.  Simultaneous determination of ledipasvir, sofosbuvir and its metabolite in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study. , 2016, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.